HOME >> BIOLOGY >> NEWS
Scientists follow familiar TRAIL to new cancer therapy

A new study identifies a combination therapy that may sensitize human cancer cells to a promising treatment currently being used in clinical trials. The research, published in the July issue of the journal Cancer Cell, published by Cell Press, provides a pharmacological method for enhancing the potency and effectiveness of a tumor necrosis factor (TNF) death receptor ligand against a variety of human cancers.

Potency and lack of toxicity to normal tissues make activation of TNF-a-related apoptosis-inducing ligand (TRAIL) death receptor signaling an attractive and exciting target for cancer therapy, and it is currently being tested in clinical trials. However, most cancer cells have defects in their ability to die via a cell death pathway called apoptosis, and unfortunately, TRAIL therapy is not effective in cells that have certain defects in apoptotic pathways. Dr. Wafik S. El-Deiry from the University of Pennsylvania School of Medicine and colleagues designed a series of studies to gain a better understanding of TRAIL-associated cell signaling pathways in cancer cells and to look for ways to pharmacologically optimize TRAIL therapy.

Dr. El-Deirys group had previously established that c-Myc is a key mediator of TRAIL-induced apoptosis and that cancer cells lacking c-Myc and a functional apoptotic pathway were resistant to TRAIL. In the current study, the researchers demonstrated that expression of c-Myc in TRAIL-resistant human colon cancer cells sensitized the cells to TRAIL, even when the cells had intrinsic apoptotic defects. The researchers observed that TRAIL induced expression of two potent antiapoptotic molecules, Mcl-1 and cIAP2, and that c-Myc repressed both molecules.

The researchers also discovered that the multikinase inhibitor sorafenib prevented TRAIL-mediated induction of Mcl-1 and cIAP2, and although it had little effect on the killing of TRAIL-resistant cells when administered alone, combination with TRAIL caused
'"/>

Contact: Erin Doonan
edoonan@cell.com
617-397-2802
Cell Press
9-Jul-2007


Page: 1 2

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Scientists prove that disputed Korean stem cell line comes from an unfertilized egg and not cloning
3. Scientists move closer to bio-engineered bladders
4. Scientists find stem cell switch
5. Scientists discover new way to study nanostructures
6. Scientists a step closer to understanding how anaesthetics work in the brain
7. Scientists to make news at Computational Biology Conference
8. Accident-prone? Scientists link brain function to knee injuries
9. Scientists take next step in understanding potential target for ovarian cancer treatment
10. Scientists find brown fat master switch
11. Scientists identify 2 distinct Parkinsons networks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/8/2019)... NEW HOPE, Pa. (PRWEB) , ... May 08, ... ... marketing research firm, announced today that business professional Carol S. Mann has agreed ... joined the company as President and Chief Operating Officer, effective immediately. They will ...
(Date:5/7/2019)... ... 07, 2019 , ... AMGtime will be exhibiting at the ... May 15- 17. At booth #226, AMGtime will be showcasing their comprehensive offerings ... mobile apps, specialized industry solutions, advanced add-on modules, seamless integrations, and more. Payroll ...
(Date:4/27/2019)... ANGELES (PRWEB) , ... April ... ... (SDi) flagship market research study " 2019 Global Assessment Report: The Laboratory ... different product categories is presented in 10 sections that include chromatography, life ...
Breaking Biology News(10 mins):
(Date:5/14/2019)... ... 2019 , ... Gateway Genomics , a leading developer of prenatal and ... 5,000 square feet. , “This past year has seen exponential growth for the ... Chris Jacob. “The SneakPeek At-Home test, which is mailed directly to our customers who ...
(Date:5/7/2019)... ... May 06, 2019 , ... "The new Liquid Nitrogen Best ... being asked to store cellular products being used in adoptive therapy research ... world leaders, who have shared their expertise in building and managing facilities to ...
(Date:5/4/2019)... ... May 03, 2019 , ... Diopsys Inc, the world leader ... Response vision test, a new full field electroretinography (ffERG) protocol designed to ... million Americans will have glaucoma, with black Americans having the highest prevalence rate. ...
(Date:5/2/2019)... ... ... The centuries old practice of brewing beer thrives today across a wide ... home brewing clubs scattered across the nation. , But proper beer brewing, on ... a superb product. Students at South Dakota School of Mines & Technology ...
Breaking Biology Technology:
Cached News: